Brief: ADC Therapeutics Announces Updated Lotis-2 Results
09/06/2023 13:27
June 9 (Reuters) - ADC Therapeutics SA ADCT.N :
* ADC THERAPEUTICS ANNOUNCES UPDATED LOTIS-2 RESULTS
DEMONSTRATING
DURABLE, LONG-TERM RESPONSES OF ZYNLONTA® IN RELAPSED/REFRACTORY
DLBCL
* ADC THERAPEUTICS SA - NO NEW SAFETY SIGNALS WERE
IDENTIFIED
Source text for Eikon: ID:nGNXccw6pM
Further company coverage: ADCT.N
(reuters.briefs@thomsonreuters.com)
Recent news on Adc Therapeutics
See all newsBrief: Adc Therapeutics Announces Comprehensive Strategic Financial Restructuring Marking Key Capital Structure Improvements
ADC Therapeutics SA reports results for the quarter ended June 30 - Earnings Summary
ADC Therapeutics Q2 loss narrows; cuts 17% workforce
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview
ADC Therapeutics SA expected to post a loss of 21 cents a share - Earnings Preview